Clinical Trial Update: Berinert (C1INH) vs Placebo for DGF/IRI [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial comparing Berinert (C1 esterase inhibitor) to placebo for delayed graft function and ischemia-reperfusion injury; the study is complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• Berinert (C1 esterase inhibitor)

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: End Stage Renal Disease, Chronic Kidney Diseases | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-09-29